The effect of alpha lipoic acid on neuropathy in patients with type 2 diabetes
Phase 3
- Conditions
- Diabetes - type 2.Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecifiedE08.40
- Registration Number
- IRCT20230303057599N2
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Age 18 to 74 years,
Type 2 diabetes,
duration of diabetes more than one year,
presence of peripheral neuropathy (pain) in the examination,
symptoms of neuropathy (pain) for at least one month,
score more than three in the pain diagnostic questionnaire.
Exclusion Criteria
neurological disease such as MS
Severe liver or kidney disease
Antioxidant consumption in the last three months
The presence of cancer and malignancy and chemotherapy
Pregnancy and breastfeeding
Peripheral arterial disease
diabetic foot ulcer
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method europathy. Timepoint: At the beginning of the study and then once a month until the completion of the probationary period. Method of measurement: Physical examination.;Pain. Timepoint: At the beginning of the study and then once a month until the completion of the probationary period. Method of measurement: visual analog scale for pain.
- Secondary Outcome Measures
Name Time Method